SUVEN PHARMACEUTICALS
|
The Current P/E Ratio of SUVEN PHARMACEUTICALS is 95.94.
Share Price | ₹1,053.0 | Apr 07,2025 |
Market Cap | ₹26,808.1 Cr | |
Earnings-TTM | ₹279.4 Cr | TTM-Consolidated Results |
Price/Earnings | 95.94x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SUVEN PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹26,808.1 Cr] as on Apr 07,2025
(/) Earnings [ ₹279.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 95.94x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay 95.94 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUVEN PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SUVEN PHARMACEUTICALS
PE Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 32.02x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 34.66x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 57.36x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 4.04x.
How does SUVEN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SUVEN PHARMACEUTICALS | 279.41 | 95.94 | 26,808.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 34.85 | 400,293.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 67.58 | 139,692.0 |
CIPLA LTD | 5,000.43 | 22.36 | 111,807.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.76 | 109,404.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 16.73 | 90,843.0 |
MANKIND PHARMA LTD | 2,050.73 | 47.85 | 98,129.7 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 18.35 | 84,267.1 |
LUPIN LTD | 2,892.10 | 30.36 | 87,792.9 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.17 | 63,603.6 |
ABBOTT INDIA LTD | 1,334.46 | 46.06 | 61,469.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUVEN PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 16.73x |
Max industry PE | 95.94x |
Median industry PE | 34.85x |
Average industry PE | 41.55x |
You may also like the below Video Courses